Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis.
Lippman
S M
SM
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Toth
B B
BB
Batsakis
J G
JG
Weber
R S
RS
McCarthy
K S
KS
Hays
G L
GL
Wargovich
M J
MJ
Lee
J S
JS
Thacher
S
S
Lotan
R
R
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control; D002454:Cell Differentiation / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D015474:Isotretinoin / Q000009:adverse effects / Q000627:therapeutic use*; D007633:Keratins / Q000187:drug effects; D008297:Male; D015162:Micronucleus Tests; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000517:prevention & control*; D011498:Protein Precursors / Q000187:drug effects; D011503:Transglutaminases / Q000378:metabolism
D014408:Biomarkers, Tumor; D011498:Protein Precursors; C032253:involucrin; D007633:Keratins; D011503:Transglutaminases; D015474:Isotretinoin